Thomas Mourez

Inserm — France

Immunology and Microbiology · Life Sciences

19h-index1.3kcitations54works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(31), HIV/AIDS drug development and treatment(25), HIV/AIDS Research and Interventions(17), Hepatitis C virus research(6), Viral gastroenteritis research and epidemiology(4)

Publications53 total

In vitro replicative potential of an HIV-1/MO intergroup recombinant virus compared to HIV-1/M and HIV-1/O parental viruses
Scientific Reports·2024· 1 citedOpen Access
In vitro replicative potential of an HIV-1/MO intergroup recombinant virus compared to HIV-1/M and HIV-1/O parental viruses
Research Square (Research Square)·2023Open Access
<i>In vitro</i> replicative potential of an HIV-1/MO intergroup recombinant virus compared to HIV-1/M and HIV-1/O parental viruses
2022Open Access
Invasive meningoencephalitis as the first manifestation of hepatitis A
Journal of Viral Hepatitis·2019· 2 cited
Dynamique infectieuse et vaccinale de l’hépatite virale A chez les personnes vivant avec le VIH suivies dans un centre tertiaire
Médecine et Maladies Infectieuses·2019
Évolution des VIH-1 groupes M et O : analyse génétique comparée de 20 formes recombinantes VIH-1 inter-groupes
HAL (Le Centre pour la Communication Scientifique Directe)·2019
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients
Journal of Antimicrobial Chemotherapy·2019· 19 citedOpen Access
Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen
Journal of Antimicrobial Chemotherapy·2018· 3 cited
HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendors
EBioMedicine·2018· 23 citedOpen Access
Mumps virus: a comprehensive review
Virologie·2018· 3 citedOpen Access
Le virus des oreillons
Virologie·2018· 2 citedOpen Access
Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir
Journal of Antimicrobial Chemotherapy·2018· 19 citedOpen Access
Detection of numerous HIV-1/MO recombinants in France
AIDS·2018· 10 citedOpen Access
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)
Journal of Antimicrobial Chemotherapy·2018· 3 citedOpen Access
Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals
Journal of Medical Virology·2018· 3 cited
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen
Clinical Infectious Diseases·2017· 23 citedOpen Access
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM
EBioMedicine·2017· 11 citedOpen Access
Performance of 9 rapid diagnostic HIV tests on a wide panel of whole blood samples
HAL (Le Centre pour la Communication Scientifique Directe)·2017Open Access
A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping
Journal of Clinical Microbiology·2017· 51 citedOpen Access
Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon
Retrovirology·2017· 36 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jean‐Christophe Plantier(25), Élodie Alessandri-Gradt(12), Astrid Vabret(11), Fabienne De Oliveira(9), Julia Dina(8), Constance Delaugerre(8), Hélène Le Guillou‐Guillemette(8), F. Freymuth∘(7), Véronique Lemee(7), Stéphanie Raymond(7), Anne Maillard(7), Audrey Mirand(7), Diane Descamps(7), Sophie Vallet(7), Marie‐Laure Chaix(6), Corinne Amiel(6), Laurence Bocket(6), Magali Bouvier‐Alias(6), Anne‐Geneviève Marcelin(6), Jacques Izopet(6)